Cochrane Evidence Synthesis and Methods ►

Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei

The aim of this work is to evaluate the efficacy of cytoreductive surgery alone versus cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), on patient benefits, complications and short-term outcomes in patients with pseudomyxoma peritonei (PMP).

This is a protocol.

Published:

29 October 2018

Authors:

Pasquali S, Sommariva A, Mahteme H, Suo T, Ma H, Tropea S, Steenberg JL, Mocellin S

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Pasquali S, Sommariva A, Mahteme H, Suo T, Ma H, Tropea S, Steenberg JL, Mocellin S. Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD005659. DOI: 10.1002/14651858.CD005659.pub3